CeCors Company Insiders
| CEOS Stock | USD 0.01 0.0004 5.13% |
CeCors employs about 6 people. The company is managed by 7 executives with a total tenure of roughly 17 years, averaging almost 2.0 years of service per executive, having 0.86 employees per reported executive. Breaking down CeCors' management performance can provide insight into the firm performance.
| James Fiedler Chairman Chairman, CEO and Pres |
CeCors |
CeCors Management Team Effectiveness
The company has return on total asset (ROA) of (1.7972) % which means that it has lost $1.7972 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.261) %, meaning that it created substantial loss on money invested by shareholders. CeCors' management efficiency ratios could be used to measure how well CeCors manages its routine affairs as well as how well it operates its assets and liabilities.CeCors Workforce Comparison
CeCors Inc is rated fifth in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is currently estimated at about 941. CeCors maintains roughly 6.0 in number of employees contributing less than 1% to all equities under Medical Instruments & Supplies industry.
CeCors Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. CeCors Inc Price Series Summation is a cross summation of CeCors price series and its benchmark/peer.
CeCors Notable Stakeholders
A CeCors stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CeCors often face trade-offs trying to please all of them. CeCors' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CeCors' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| James Fiedler | Chairman, CEO and Pres | Profile | |
| John Gustin | Head Devel | Profile | |
| Robert Gardiner | Pres Director | Profile | |
| Sukhinder Kalsi | CFO Director | Profile | |
| Jasbir MD | S Treasurer | Profile | |
| Allen MD | VP Director | Profile | |
| Mark Perkell | VP Counsel | Profile |
About CeCors Management Performance
The success or failure of an entity such as CeCors Inc often depends on how effective the management is. CeCors management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CeCors management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CeCors management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. CECORS INC operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 6 people.
Please note, the imprecision that can be found in CeCors' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CeCors Inc. Check CeCors' Beneish M Score to see the likelihood of CeCors' management manipulating its earnings.
CeCors Workforce Analysis
Traditionally, organizations such as CeCors use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CeCors within its industry.CeCors Manpower Efficiency
Return on CeCors Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.6M | |
| Net Loss Per Executive | 1.3M |
Additional Tools for CeCors Pink Sheet Analysis
When running CeCors' price analysis, check to measure CeCors' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CeCors is operating at the current time. Most of CeCors' value examination focuses on studying past and present price action to predict the probability of CeCors' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CeCors' price. Additionally, you may evaluate how the addition of CeCors to your portfolios can decrease your overall portfolio volatility.